During Drosophila development, cells with elevated levels of the Myc oncoprotein grow faster than, and induce cell death in, nearby wild-type cells, suggesting how inappropriate Myc over-expression provides cells with a competitive advantage that can lead to cancer. In the second study, de la Cova et al.
Those of us who work on Drosophila are often asked by scientists and lay people alike whether flies 'get cancer'. The answer depends on what you mean by cancer. Certainly, flies do not get cancer the disease that kills so many people and for which so much research is devoted, but fly cells can display many of the cell biological properties that human cancer cells do, including lack of cell polarity, inappropriate proliferation and metastasis [1] [2] [3] . At the basis of this is conservation of proteins at the heart of regulatory networks that go awry in cancer, such as pRB, p53, and many oncogene products [4] . Included in the latter group is the Myc transcription factor, which controls the expression of a great many genes involved in cell growth and proliferation [5] . Myc over-expression occurs in many human cancers and often correlates with highly aggressive tumors. Two new studies [6, 7] have used the powerful genetic tools of Drosophila to suggest a way that tumor cells with inappropriately elevated levels of Myc might acquire a significant growth advantage over neighboring wild-type cells.
The expression profile of Myc is consistent with a role in promoting growth and proliferation. Myc expression is high in embryogenesis and in rapidly dividing tissues, and low in quiescent and differentiating cells. Furthermore, Myc expression is directly induced in response to mitogenic stimuli, suggesting that it acts early in growth regulatory networks. Myc interacts with Max and functions as both a transcriptional activator and a repressor [8] [9] [10] . Myc-Max heterodimers bind DNA and recruit chromatin modifying factors which influence the rate of transcription of target genes. Growth-promoting targets of Myc-Max include cellcycle regulators and ribosomal protein genes, suggesting that Myc exerts its effect by increasing both cell division rates and biosynthetic capacity.
A phenomenon known as cell competition has been described in Drosophila whereby cells with reduced growth rates, typically achieved by reducing the dose of a ribosomal protein gene, are eliminated via apoptosis from developing tissues, but only if they are situated among cells with higher growth rates [11] [12] [13] [14] . The new studies [6, 7] show that such cell competition can be In the second study, de la Cova et al. [7] devised a clever 'three clone assay' in which three groups of cells with different and phenotypically distinguishable genotypes were created simultaneously, allowing for direct measurements and comparisons of growth rates between different groups of cells within a single developing tissue, the wing disc (Figure 1) . Importantly, two of these clones, one over-expressing Myc and the other with a wild-type level of Myc, were generated from the same mitotic recombination event and developed in close proximity to one another. The third clone, also expressing normal Myc levels, was generated independently from the sibling clones and served as a neutral control for growth rate. The Myc over-expressing clone grew to a larger size than both the sibling and neutral clones. Moreover, the sibling clone adjacent to the Myc over-expressing clone was always smaller than the neutral clones generated at a distance from the sibling pair, suggesting that the Myc over-expressing clones impeded the growth of sibling clones (Figure 1) . Consistent with this inference, neutral clones located close to Myc over-expressing clones were smaller than neutral clones located far from Myc over-expressing clones. Again, this ability of Myc-over-expressing cells to out-compete their neighbors was due to the induction of apoptosis in the neighboring cells, in addition to their having an overall faster rate of growth. Interestingly, de la Cova et al. [7] suggest that cell competition via apoptosis plays a role in regulating normal organ size. This is because in Myc mosaic wing discsthose with a mixture of cells expressing different amounts of Myc -the cells with elevated Myc eliminate their lower expressing neighbors, always producing wings of normal size [7] . In contrast, when Myc was ubiquitiously over-expressed or when apoptosis was suppressed in Myc over-expressing mosaic wing discs, competition did not occur and larger than normal wings were produced [7] . These studies [6, 7] show that Myc has a role in the regulation of cell proliferation beyond its ability to induce transcription of growth-promoting genes. Cells with high levels of Myc expression can act as supercompetitors that are capable of both out-growing and inducing death in nearby cells with lower Myc levels. Although the mechanism of apoptotic induction is unclear, it involves the activation of genes that are known to trigger apoptosis in Drosophila cells, such as hid [7] . Super-competition appears not to be a general property of a relative increase in growth rate, because the activation of other growth-promoting pathways did not cause apoptosis in neighboring cells [7] .
These observations, together with the wellestablished evidence that Myc plays a prominent role in the induction of growth-promoting gene expression, specifically the ribosomal protein genes, suggest a mechanism by which deregulated Myc expression can initiate tumor formation. Oncogenic mutations that lead to increased Myc expression [17] [18] [19] [20] 
